The acceptance of the wide-spread α-synuclein pathology in PD, both in many brain areas outside the basal ganglia and in the periphery, has been linked to the concept of a progressive and possibly spreading disease process with a long pre-symptomatic phase, and to the importance of non-motor symptoms [3]. This evidence concerns the gene SNCA and Parkinson disease.